A new antigens formulation against pandemic flu (A H1N1 virus) proved six times more effective than other vaccines.
CALIXAR and VirPath develop an innovative manufacturing process for high performance influenza vaccines
September 23, 2014
Expression of fully native proteins
Identification of relevant targets
Target functional isolation and stabilization
Active custom proteins
Structure-based drug discovery
Immunoassays
Vaccine development
Functional antigen discovery
Conformational antibody development
Expression of fully native proteins
Identification of relevant targets
Target functional isolation and stabilization
Active custom proteins
Structure-based drug discovery
Immunoassays
Vaccine development
Functional antigen discovery
Conformational antibody development
Secure and boost
your discovery programs
Starting from native material or recombinant systems, we succeed with all types of proteins: Kinases, Phosphatases, Ubiquitins, Epigenetic Proteins, GPCRs, Ion Channels, Transporters, Receptors and Viral Proteins.
